top of page
matthew-guay-Q7wDdmgCBFg-unsplash.jpg
bg-dégradé.png

News

Q4 and year-end 2025 results

Apr 30, 2026

Q4 and year-end 2025 results

LSL PHARMA GROUP REPORTS ITS FOURTH QUARTER AND YEAR-END 2025 RESULTS

PREVIOUS NEWS

Apr 30, 2026

Q4 and year-end 2025 results

Apr 30, 2026

Résultats du T4 et exercice 2025

Apr 9, 2026

Private label Loratadine 10 mg for Juno OTC

bottom of page